Clinical Trials Directory

Trials / Completed

CompletedNCT03661164

Iontophoretic Transepithelial Corneal Cross-linking in Pediatric Patients

Factors Influencing Keratoconus Progression After Iontophoretic Transepithelial Corneal Cross-linking in Pediatric Patients: Three Year Follow up

Status
Completed
Phase
Study type
Observational
Enrollment
22 (actual)
Sponsor
Luca Buzzonetti · Academic / Other
Sex
All
Age
8 Years – 18 Years
Healthy volunteers

Summary

To report three year follow up in pediatric patients with keratoconus after iontophoretic transepithelial corneal cross-linking (CXL) to assess preoperative factors that may influence ectasia progression

Detailed description

Purpose: To report three year follow up in pediatric patients with keratoconus after iontophoretic transepithelial corneal cross-linking (CXL) to assess preoperative factors that may influence ectasia progression. Methods: Thirthyfive eyes of 22 consecutive pediatric patients (mean age 14.3±2.5 years) with keratoconus are evaluated in this retrospective study. Subgroup A and B are made up in function of progression in maximum K (Kmax,) defined as steepening of 1.0 diopter or more recorded three year after CXL. Corrected distance visual acuity (CDVA), spherical equivalent, topographic cone location, Kmax, posterior elevation of the thinnest point and thinnest point are evaluated. A paired Student t test is used to compare preoperative and 12, 24, and 36 month postoperative da-ta. A P value \<0.05 was considered significant.

Conditions

Interventions

TypeNameDescription
PROCEDUREcorneal cross linkingIontophoretic corneal cross linking

Timeline

Start date
2013-05-01
Primary completion
2015-06-30
Completion
2015-06-30
First posted
2018-09-07
Last updated
2018-09-11

Source: ClinicalTrials.gov record NCT03661164. Inclusion in this directory is not an endorsement.